New mtec award entitled, "development of a fieldable direct osmotherapy device for the point-of-injury reduction of cerebral edema following penetrating traumatic brain injury."
Ended Awarded Last action
- Contract number
- W81XWH2290008
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,340,612
Award facts
- Contract value 100% obligated
- $1,340,612.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $364,868 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $399,150 | |
| Original award | $576,594 |
About this award
The Defense Health Agency awarded Medical Technology Enterprise Consortium (MTEC) a $1.34 million Other Transaction Order on March 3, 2022, for the development of a fieldable direct osmotherapy device designed to reduce cerebral edema at the point of injury following penetrating traumatic brain injury. This research project (MTEC-21-06-MPAI-012) is scheduled for completion by March 31, 2026, and will be performed in Summerville, South Carolina. The contract leverages MTEC's established consortium model, which mobilizes partnerships across academia, industry, and government to rapidly prototype innovative medical solutions for military healthcare applications. This award carries no set-aside designation, reflecting MTEC's unrestricted access to federal contracting mechanisms.
MTEC, a nonprofit medical technology accelerator registered since December 2015, operates under a primary Other Transaction Indefinite Delivery Vehicle with the Defense Health Agency valued at $3.47 million (awarded January 2024) that enables streamlined task order execution for diverse medical technology initiatives. The organization has demonstrated significant expertise in trauma care innovation and operational medicine through a portfolio exceeding $500 million in prototype development, research, and medical countermeasure work. This cerebral edema mitigation project aligns with MTEC's established focus on traumatic brain injury solutions and reflects the Defense Health Agency's investment in advanced medical technologies that enhance warfighter readiness and survival outcomes in austere operational environments.
Quick answers
Who was awarded contract W81XWH2290008?
W81XWH2290008 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on March 3, 2022.
How much is contract W81XWH2290008 worth?
The government has obligated $1,340,612 on W81XWH2290008.
Is contract W81XWH2290008 an order under another contract?
Yes. W81XWH2290008 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract W81XWH2290008 competed?
The extent of competition for W81XWH2290008 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award